S

Systimmune

Develops bispecific antibodies and ADCs

Director/Senior Director of Analytical

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeBothell, WA, USA$190k - $280k /yr

About the Job

Requirements

  • An advanced degree in Analytical Chemistry, Biochemistry, or a related field is required; a PhD is preferred.
  • At least 10 years of laboratory experience in an industrial setting is required.
  • Extensive experience in analytical development for biologics, including method validation and technology transfer, is required.
  • Proven experience supporting co-development alliances and global technology transfers is required.
  • Experience in antibody or antibody-drug conjugate drug development is required.
  • A deep understanding of the design, development, optimization, and technology transfer of antibody or antibody-drug-conjugate manufacturing processes is required.
  • Expertise in developing, optimizing, troubleshooting, and transferring analytical methods for antibodies or antibody-drug conjugates is required.
  • Proficiency in analyzing and interpreting complex datasets from multiple methodologies is required.
  • Expertise in method robustness assessment, validation, and testing is required.
  • Demonstrated experience in cross-functional and functional leadership roles is required.
  • Proficiency in drafting, reviewing, approving, and supporting regulatory filings and responses is required.
  • Comprehensive knowledge of International Council for Harmonisation and U.S. Food and Drug Administration regulations and guidance for biologics and antibody-drug conjugates is required.
  • Proficiency in reading and writing Mandarin Chinese is required.

Responsibilities

  • Lead and manage the Analytical teams.
  • Develop strategies for analytical method development, validation, and technology transfer.
  • Drive innovation in integrated discovery and manufacturability for novel biologics.
  • Develop and implement analytical strategies for antibody and antibody-drug-conjugate development, including phase-appropriate analytical development, characterization, and release strategies.
  • Collaborate with cross-functional teams to establish critical quality attributes and specifications.
  • Oversee analytical development, release, and stability testing at external partners.
  • Ensure the integrity, organization, and integration of analytical datasets to support development and regulatory submissions.
  • Support regulatory filings, including Investigational New Drug and Biologics License Applications, with analytical data and interpretation.
  • Partner with quality-control teams in Chengdu to support product release, characterization, and scaling.
  • Partner with the Director of Process Development on process analytical technology workflows.
  • Participate in cross-functional process development and chemistry, manufacturing, and controls working groups to meet project milestones.
  • Work with the manufacturing facility and research and development center in Chengdu to align process development, scale-up, and manufacturing activities.
  • Facilitate technology transfer and maintain consistency between sites, quality standards, and regulatory compliance.
  • Identify and manage processes and ensure technology transfer for scale-up and good manufacturing practice manufacturing, particularly between the United States and China.

About the Company

Systimmune

Develops bispecific antibodies and ADCs

Systimmune is a biopharmaceutical company that develops antibody-based cancer therapies, including bispecific and trispecific antibodies and antibody-drug conjugates (ADCs). These products are designed to act on the solid tumor micro-environment to directly attack tumors and/or to activate the immune system to fight cancer. The company uses multiple immuno-oncology platforms and experienced scientists to create biologics that intervene in the tumor environment in systematic ways. Compared with competitors, Systimmune emphasizes integrating several antibody-based modalities (bispecifics, trispecifics, and ADCs) and a deep focus on the solid tumor micro-environment, aiming to translate biological insight into targeted, immune-engaging therapies. The goal is to produce biologics that effectively modulate the tumor environment and mobilize the body's own immune response to destroy cancer cells.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
Redmond, WA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Systimmune

See more jobs